JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB89364

Recombinant human PKM2 protein (Active) (His tag N-Terminus)

5

(1 Review)

|

(9 Publications)

Recombinant human PKM2 protein (Active) (His tag N-Terminus) is a Human Full Length protein, in the 1 to 531 aa range, expressed in Escherichia coli, with >95%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE, WB, FuncS.

View Alternative Names

OIP3, PK2, PK3, PKM2, PKM, Pyruvate kinase PKM, Cytosolic thyroid hormone-binding protein, Opa-interacting protein 3, Pyruvate kinase 2/3, Pyruvate kinase muscle isozyme, Threonine-protein kinase PKM2, Thyroid hormone-binding protein 1, Tumor M2-PK, Tyrosine-protein kinase PKM2, p58, CTHBP, OIP-3, THBP1

2 Images
Western blot - Recombinant human PKM2 protein (Active) (His tag N-Terminus) (AB89364)
  • WB

Unknown

Western blot - Recombinant human PKM2 protein (Active) (His tag N-Terminus) (AB89364)

All lanes:

Anti-PKM antibody (<a href='/en-us/products/unavailable/pkm-antibody-ab85542'>ab85542</a>) at 1/1000 dilution

All lanes:

Western blot - Recombinant human PKM2 protein (Active) (His tag N-Terminus) (ab89364) at 0.1 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution

true

Exposure time: 30s

SDS-PAGE - Recombinant human PKM2 protein (Active) (His tag N-Terminus) (AB89364)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant human PKM2 protein (Active) (His tag N-Terminus) (AB89364)

3ug of reduced ab89364 on SDS-PAGE under reducing condition and visualized by coomassie blue stain.

Key facts

Purity

>95% SDS-PAGE

Endotoxin level

< 1 EU/µg

Expression system

Escherichia coli

Tags

His tag N-Terminus

Applications

FuncS, WB, SDS-PAGE

applications

Biologically active

Yes

Biological activity

Specific activity: > 25,000 pmol/min/ug.

One unit will convert 1.0 pmole of phospho(enol)pyruvate to pyruvate per minute at pH 7.5 at 37C.

Accession

P14618

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 8 Constituents: 10% Glycerol (glycerin, glycerine), 0.316% Tris HCl

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>ab89364 can be used as a WB positive control in conjunction with <a href='/en-us/products/unavailable/pkm-antibody-ab85542'>ab85542</a>.</p>" }, "FuncS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p><ol> <li>Prepare a 1.45 ml reaction mixture into a suitable container.<br> - Reaction mixture: 100mM Tris-HCl pH 7.5, 7.6 mM ADP, 15 mM MgCl2, 74 mM KCl, 0.2 mM Beta-NADH 5.2 mM PEP, 0.025 units Recombinant LDHA protein (<a href='/en-us/products/proteins-peptides/recombinant-human-lactate-dehydrogenase-protein-active-ab93699'>ab93699</a>)</li> <li>Add 50ul of recombinant PKM2 protein solution with various concentrations (0.5ug, 1ug)</li> <li>Read the decrease in A340nm in kinetic mode for 10 minutes.</li></ol>" } } }

Product details

Endotioxin Levels determined by LAL method.

Sequence info

[{"sequence":"MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","proteinLength":"Full Length","predictedMolecularWeight":"60.1 kDa","actualMolecularWeight":null,"aminoAcidEnd":531,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"P14618","tags":[{"tag":"His","terminus":"N-Terminus"}]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
True

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The target PKM2 also known as pyruvate kinase M2 is a type of enzyme that catalyzes the final step of glycolysis converting phosphoenolpyruvate (PEP) to pyruvate and generating ATP. The PKM2 protein has a molecular weight of about 58 kDa. PKM2 expresses in various tissues including muscles and certain cancer cells where it plays a significant role in metabolic processes. It exists in different isoforms with PKM1 being an alternative form found in pacemaker locations such as the brain and heart.
Biological function summary

PKM2 is important in cellular energy metabolism and regulates the balance between glycolysis and oxidative phosphorylation. This enzyme can exist in both dimeric and tetrameric forms with its activity level depending on its structural state. PKM2 is part of multi-protein complexes that interact with other metabolic enzymes influencing metabolic pathways that impact growth and proliferation in cells.

Pathways

PKM2 is significant in the glycolytic pathway and is also involved in the regulation of the pentose phosphate pathway. It interacts with proteins like HIF-1α a transcription factor that responds to low oxygen levels to modulate metabolic and growth pathways under hypoxic conditions. This interaction affects biosynthetic processes and energy production in rapidly dividing cells such as those in tumors.

PKM2 has a link to cancer and metabolic diseases. PKM2 is often re-expressed in cancer cells where it shifts cellular metabolism to favor rapid growth and proliferation a process known as the Warburg effect. Additionally PKM2 has connections to metabolic disorders such as type 2 diabetes where dysregulated glucose metabolism plays an important role. PKM2's interaction with proteins like Akt and mTOR can impact signaling pathways associated with cancer progression and metabolic dysregulation.

Specifications

Form

Liquid

Additional notes

ab89364 is purified using conventional chromatography techniques.

General info

Function

Catalyzes the final rate-limiting step of glycolysis by mediating the transfer of a phosphoryl group from phosphoenolpyruvate (PEP) to ADP, generating ATP (PubMed : 15996096, PubMed : 1854723, PubMed : 20847263). The ratio between the highly active tetrameric form and nearly inactive dimeric form determines whether glucose carbons are channeled to biosynthetic processes or used for glycolytic ATP production (PubMed : 15996096, PubMed : 1854723, PubMed : 20847263). The transition between the 2 forms contributes to the control of glycolysis and is important for tumor cell proliferation and survival (PubMed : 15996096, PubMed : 1854723, PubMed : 20847263).. Isoform M2. Isoform specifically expressed during embryogenesis that has low pyruvate kinase activity by itself and requires allosteric activation by D-fructose 1,6-bisphosphate (FBP) for pyruvate kinase activity (PubMed : 18337823, PubMed : 20847263). In addition to its pyruvate kinase activity in the cytoplasm, also acts as a regulator of transcription in the nucleus by acting as a protein kinase (PubMed : 18191611, PubMed : 21620138, PubMed : 22056988, PubMed : 22306293, PubMed : 22901803, PubMed : 24120661). Translocates into the nucleus in response to various signals, such as EGF receptor activation, and homodimerizes, leading to its conversion into a protein threonine- and tyrosine-protein kinase (PubMed : 22056988, PubMed : 22306293, PubMed : 22901803, PubMed : 24120661, PubMed : 26787900). Catalyzes phosphorylation of STAT3 at 'Tyr-705' and histone H3 at 'Thr-11' (H3T11ph), leading to activate transcription (PubMed : 22306293, PubMed : 22901803, PubMed : 24120661). Its ability to activate transcription plays a role in cancer cells by promoting cell proliferation and promote tumorigenesis (PubMed : 18337823, PubMed : 22901803, PubMed : 26787900). Promotes the expression of the immune checkpoint protein CD274 in BMAL1-deficient macrophages (By similarity). May also act as a translation regulator for a subset of mRNAs, independently of its pyruvate kinase activity : associates with subpools of endoplasmic reticulum-associated ribosomes, binds directly to the mRNAs translated at the endoplasmic reticulum and promotes translation of these endoplasmic reticulum-destined mRNAs (By similarity). Plays a role in caspase independent cell death of tumor cells (PubMed : 17308100).. Isoform M1. Pyruvate kinase isoform expressed in adult tissues, which replaces isoform M2 after birth (PubMed : 18337823). In contrast to isoform M2, has high pyruvate kinase activity by itself and does not require allosteric activation by D-fructose 1,6-bisphosphate (FBP) for activity (PubMed : 20847263).

Sequence similarities

Belongs to the pyruvate kinase family.

Post-translational modifications

ISGylated.. Under hypoxia, hydroxylated by EGLN3.. Acetylation at Lys-305 is stimulated by high glucose concentration, it decreases enzyme activity and promotes its lysosomal-dependent degradation via chaperone-mediated autophagy.. Isoform M2. Acetylated at Lys-433 by EP300, leading to impair phosphoenolpyruvate substrate-binding and promote its homodimerization and subsequent translocation to the nucleus (PubMed:24120661). Deacetylation at Lys-433 by SIRT6 promotes its nuclear export into the cytoplasm, leading to suppress its nuclear localization and oncogenic function (PubMed:26787900).. Isoform M2. S-nitrosylation at Cys-423 and Cys-424 inhibits homotetramerization and pyruvate kinase activity (PubMed:30487609). S-nitrosylation is indirectly inhibited by AKR1A1 which degrades S-nitroso-CoA, a cofactor required to S-nitrosylate proteins (PubMed:30487609).. FGFR1-dependent tyrosine phosphorylation is reduced by interaction with TRIM35.

Subcellular localisation

Nucleus

Product protocols

Target data

Catalyzes the final rate-limiting step of glycolysis by mediating the transfer of a phosphoryl group from phosphoenolpyruvate (PEP) to ADP, generating ATP (PubMed : 15996096, PubMed : 1854723, PubMed : 20847263). The ratio between the highly active tetrameric form and nearly inactive dimeric form determines whether glucose carbons are channeled to biosynthetic processes or used for glycolytic ATP production (PubMed : 15996096, PubMed : 1854723, PubMed : 20847263). The transition between the 2 forms contributes to the control of glycolysis and is important for tumor cell proliferation and survival (PubMed : 15996096, PubMed : 1854723, PubMed : 20847263).. Isoform M2. Isoform specifically expressed during embryogenesis that has low pyruvate kinase activity by itself and requires allosteric activation by D-fructose 1,6-bisphosphate (FBP) for pyruvate kinase activity (PubMed : 18337823, PubMed : 20847263). In addition to its pyruvate kinase activity in the cytoplasm, also acts as a regulator of transcription in the nucleus by acting as a protein kinase (PubMed : 18191611, PubMed : 21620138, PubMed : 22056988, PubMed : 22306293, PubMed : 22901803, PubMed : 24120661). Translocates into the nucleus in response to various signals, such as EGF receptor activation, and homodimerizes, leading to its conversion into a protein threonine- and tyrosine-protein kinase (PubMed : 22056988, PubMed : 22306293, PubMed : 22901803, PubMed : 24120661, PubMed : 26787900). Catalyzes phosphorylation of STAT3 at 'Tyr-705' and histone H3 at 'Thr-11' (H3T11ph), leading to activate transcription (PubMed : 22306293, PubMed : 22901803, PubMed : 24120661). Its ability to activate transcription plays a role in cancer cells by promoting cell proliferation and promote tumorigenesis (PubMed : 18337823, PubMed : 22901803, PubMed : 26787900). Promotes the expression of the immune checkpoint protein CD274 in BMAL1-deficient macrophages (By similarity). May also act as a translation regulator for a subset of mRNAs, independently of its pyruvate kinase activity : associates with subpools of endoplasmic reticulum-associated ribosomes, binds directly to the mRNAs translated at the endoplasmic reticulum and promotes translation of these endoplasmic reticulum-destined mRNAs (By similarity). Plays a role in caspase independent cell death of tumor cells (PubMed : 17308100).. Isoform M1. Pyruvate kinase isoform expressed in adult tissues, which replaces isoform M2 after birth (PubMed : 18337823). In contrast to isoform M2, has high pyruvate kinase activity by itself and does not require allosteric activation by D-fructose 1,6-bisphosphate (FBP) for activity (PubMed : 20847263).
See full target information PKM

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Cell reports 43:115001 PubMed39580803

2024

AMPK regulates Bcl2-L-13-mediated mitophagy induction for cardioprotection.

Applications

Unspecified application

Species

Unspecified reactive species

Tomokazu Murakawa,Jumpei Ito,Mara-Camelia Rusu,Manabu Taneike,Shigemiki Omiya,Javier Moncayo-Arlandi,Chiaki Nakanishi,Ryuta Sugihara,Hiroki Nishida,Kentaro Mine,Roland Fleck,Min Zhang,Kazuhiko Nishida,Ajay M Shah,Osamu Yamaguchi,Yasushi Sakata,Kinya Otsu

Chinese medicine 19:45 PubMed38454519

2024

Cryptotanshinone inhibits PFK-mediated aerobic glycolysis by activating AMPK pathway leading to blockade of cutaneous melanoma.

Applications

Unspecified application

Species

Unspecified reactive species

Qiong Chen,Yang Liu,Yunxuan Zhu,Ziyan Zhu,Jueyao Zou,Yanhong Pan,Yin Lu,Wenxing Chen

Molecular medicine reports 27: PubMed36799163

2023

Maltol inhibits oxygen glucose deprivation‑induced chromatinolysis in SH‑SY5Y cells by maintaining pyruvate level.

Applications

Unspecified application

Species

Unspecified reactive species

Shuyan Zhang,Xinyue Zhang,Xuanzhong Wang,Chen Li,Chuan He,Tianfei Luo,Pengfei Ge

Cell death discovery 8:306 PubMed35790734

2022

Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan-Rong Liu,Dan-Dan Song,Dong-Min Liang,You-Jie Li,Yun-Fei Yan,Hong-Fang Sun,Mei-Ling Zhang,Jin-Xia Hu,Yu-Long Zhao,Yan Liang,Yan-Mei Li,Zhen Yang,Ran-Ran Wang,Hou-Feng Zheng,Pingyu Wang,Shu-Yang Xie

Frontiers in pharmacology 13:830312 PubMed35754468

2022

Renoprotection of Microcystin-RR in Unilateral Ureteral Obstruction-Induced Renal Fibrosis: Targeting the PKM2-HIF-1α Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Ren,Jie Wang,Wenwen Guo,Jingwen Chen,Xin Wu,Shubo Gu,Lizhi Xu,Zhiwei Wu,Yaping Wang

Journal of the American Heart Association 11:e024854 PubMed35656980

2022

Pyruvate Kinase M2 Protects Heart from Pressure Overload-Induced Heart Failure by Phosphorylating RAC1.

Applications

Unspecified application

Species

Unspecified reactive species

Le Ni,Bowen Lin,Lingjie Hu,Ruoyu Zhang,Fengmei Fu,Meiting Shen,Jian Yang,Dan Shi

Bioengineered 13:13089-13107 PubMed35615982

2022

CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Chaoting Zhou,Luyang Wang,Wanye Hu,Lusheng Tang,Ping Zhang,Yan Gao,Jing Du,Yanchun Li,Ying Wang

Molecular oncology 15:1466-1485 PubMed33314660

2020

FOXM1D potentiates PKM2-mediated tumor glycolysis and angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Zhang,Xin Zhang,Sheng Huang,Jianfeng Chen,Peipei Ding,Qi Wang,Luying Li,Xinyue Lv,Ling Li,Pingzhao Zhang,Danlei Zhou,Wenyu Wen,Yiping Wang,Qun-Ying Lei,Jiong Wu,Weiguo Hu

Cell communication and signaling : CCS 18:25 PubMed32054489

2020

The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2.

Applications

Unspecified application

Species

Unspecified reactive species

Min Xiao,Jianling Xie,Yu Wu,Genzhu Wang,Xin Qi,Zailiang Liu,Yuying Wang,Xuemin Wang,Ashfaqul Hoque,Jon Oakhill,Christopher G Proud,Jing Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com